Consulting a healthcare professional is essential to determine the most suitable GLP-1 for achieving weight loss goals
In agreement with the results of Tang, no changes in liver fat content and surrogate biomarkers of fibrosis were shown in a RCT comparing the effect of a 12-week course with liraglutide versus sitagliptin or placebo among 52 overweight diabetic patients on metformin or sulphanylurea
If you want to build around that focus, the Gut Health Supplements collection can also complement a broader wellness routine
Thus, even plans sponsors who have so far elected not to cover GLP-1s for anti-obesity may still need to formulate a strategy to cover them as doctors begin to prescribe a greater variety of GLP-1s for a greater variety of conditions
11 In August 2025, semaglutide received accelerated FDA approval for metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced fibrosis, based on interim Phase 3 trial results in which 62.9% of semaglutide-treated patients achieved steatohepatitis resolution without worsening fibrosis versus 34.3% on placebo
When administered in studies, the PT-141 peptide therapy works by activating central melanocortin receptors in the brain, which play a key role in regulating sexual arousal and desire